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Abstract
Intra-abdominal and biliary infections are significant cause of morbidity and mortality for the transplant recipients,
specifically in the early post-operative period, reflecting substantial immunosuppression. In renal transplant
recipients, there is no reported increased risk for pyogenic liver abscess as compared to general population. The
diagnosis of hepatic abscess in a transplant recipient can be challenging since presentation could be atypical and
the signs and symptoms might be insidious and subtle. If a hepatic abscess is missed and left untreated, it is
potentially lethal; hence, an early diagnosis and timely initiation of appropriate therapy is of utmost importance, to
improve patient outcomes.
We present a case record of a 29 year old male patient who received a living unrelated renal transplant in 2007.
He presented 8 years post-transplant with a fever of unknown origin; clinical and laboratory tests did not provide any
clue to the diagnosis. However, labeled white cell scan (Leukoscan) followed by abdominal ultrasound scan (USS)
revealed an unexpected finding of a large liver abscess (5.57 × 6.05 cm). He responded well to a course of
antibiotics including metronidazole therapy besides requiring percutaneous abscess drainage.
Keywords: Renal transplant; Hepatic abscess; Amoebic abscess;
Pyogenic liver abscess
Introduction
Infection is the second most common cause of morbidity and
mortality in transplant recipients. Intra-abdominal and biliary
infections pose significant risks to transplant recipients [1,2]. However,
renal transplant recipients are not known to have increased risk of
pyogenic liver abscess as compared to general population.
We present a case record of a transplant recipient who presented
with fever of unknown origin, subsequent imaging revealed
unexpectedly large hepatic abscess.
Case Presentation
This 29 years old male patient had renal transplantation in 2007
from a living, unrelated donor. His maintenance immunosuppression
was a combination of cyclosporine, prednisolone and sirolimus. He
developed new onset diabetes after transplant (NODAT) and had been
on regular follow-up with a baseline serum creatinine level of 1.5
mg/dl.
He presented to the emergency department in July 2015 with a
history of high-grade fever for 5 days duration associated with rigors.
He denied any history of a sore throat, cough, abdominal pain, rash,
dysuria, diarrhea or any other relevant symptoms. There was no
history of contact with sick patients. However, 2 months prior to this
hospital admission he accompanied his father on a trip to India.
Clinical examination was unremarkable apart from a high-grade fever
of 39.9°C.
Investigations revealed
FBC: Haemoglobin 13.5 g/dl, WBC 18.4 × 103/ul, PLT 239000, Urea
53 mg/dl, K 3.8 mmol/l, Cr 1.6 mg/dl, Glucose 114 mg/dl; blood
culture and urine culture were negative; liver function tests (LFTs)
which were normal 3 days earlier, now are reported as mildly elevated
SGPT 65 u/l; the remaining LFTs were normal. Lactic acid 1.3 mmol/l,
ESR 30; urinary AFB was negative. Viral serology (CMV, HBs Ag, HCV
Ab) and Toxoplasmosis antibodies were all negative. Coagulation
profile was normal.
The patient was started empirically on antibiotics (initially
ceftriaxone, altered later to Piperacillin/Tazobactam), yet his fever
remained unabated. Since the source of sepsis could not be localized,
he underwent isotope leukoscan (Tc99m labeled granulocyte scan)
(Figures 1 and 2).
USS of the abdomen displayed normal appearances of the kidney
allograft with an incidental finding of a focal lesion in the right liver
lobe; measuring 5.57 × 6.05 cm, suggestive of a hepatic abscess
(Figures 3 and 4).
Given his persistent fever, antibiotic therapy has been changed to
Meropenem® and Metronidazole was added considering his recent
travel to an endemic area with amoebiasis, although the organisms
were not isolated. USS guided percutaneous drainage was performed
due to the considerable size of the abscess with good clinical response
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and relief of the fever. Culture and sensitivity for the drained pus were
reported negative for any organism including acid-fast bacilli.
We did not alter immunosuppression as the patient responded well
to the treatment plan. The patient’s condition improved significantly,
and he was discharged on antibiotics for a total of 4 weeks.
Figure 1: These images of Tc99m labeled granulocyte scan
demonstrated mildly increased isotope uptake in the transplanted
kidney suggesting mild acute rejection together with an increased
uptake in the right liver lobe.
Figure 2: Liver images from Tc99m labeled granulocyte scan show a
large cold area in the posterior aspect of the right lobe suggesting a
cystic lesion.
Figure 3: Abdominal USS showed an incidental finding of a focal
lesion measuring 5.57 × 6.05 cm in the right liver lobe, suggestive of
a hepatic abscess (white arrow).
Figure 4: A and B: These images of a non-contrast CT abdomen
show a large hypodense lesion measuring 7.5 × 7.5 × 7 cm in
segments VI and VII of the right liver lobe; corresponding to a
hepatic abscess (white arrows).
Discussion
Infection is the second most common cause of morbidity and
mortality in the transplant recipients. The risk of infection is
determined by the length of exposure to infectious agents (hospital or
community sources) and overall immunosuppressive levels. The final
immunosuppression status is affected by dosage, duration, timing of
transplant and choice of immunosuppressive medications, presence of
metabolic conditions such as diabetes mellitus, and existence of
immune-modulating viruses [1,2].
Intra-abdominal and biliary infections are expected especially in the
first year post-transplantation, reflecting heavy initial
immunosuppression regimen in the form of induction and maintained
therapy, although infections can occur at any time thereafter [1,2].
Among these infections is the development of liver abscess, which
could be pyogenic, amoebic, tuberculous, or rarely (in severely
immune-compromised patients) fungal.
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The timing of the transplant is critical in determining the causative
organisms. For instance, those recipients who shortly had an abscess
after receiving the induction therapy and have had a complicated
medical, surgical, and immunological postoperative course, then Fungi
(e.g. Aspergillus, Candida, and Mucorales species) as causative
organisms were implicated, reflecting their heavy immunosuppression
status. In contrast, chronically immunosuppressed (otherwise healthy
recipients); abscesses are usually caused by non-fungal organisms; e.g.
a pyogenic bacterial abscess, Nocardia, Toxoplasma species, TB and
amoebiasis), this could be explained by the fact that post-
transplantation immunosuppression primarily impairs T-cell rather
than B-cell functions [3-5]. 70% of hepatic abscesses are solitary, and
the right liver lobe is affected in 95% of these cases [4-7].
For the pyogenic abscess, most published data addressing the
occurrence of pyogenic liver abscess have been reported mainly in liver
transplant recipients rather than other organ recipients, reflecting
surgical and anatomical nature of this form of transplantation. Renal
transplant recipients, on the other hand, are not known to have an
increased risk of pyogenic liver abscess as compared to general
population.
Reported incidence of pyogenic hepatic abscess in the general
population varies in different countries; ranging from 1.1 and 2.3 per
100,000 in Denmark and Canada to almost 3.6 per 100,000 in the U.S.,
reaching up to 17.6 per 100,000 in Taiwan [2-9].
Microbiology of pyogenic liver abscesses demonstrated that 50%
were gram-negative organisms, 25% were gram-positive, 10% were
anaerobic organisms and 15% of cultures were sterile. Approximately
15% to 20% of abscesses have more than one organism (Polymicrobial
infections) [2-9]. Escherichia coli and Klebsiella pneumoniae are the
most common pathogens. E-coli are the most common organism
isolated in Western countries, whereas K. pneumoniae is commonly
isolated in diabetic patients in Taiwan. Enterococcus, Staphylococcus
aureus, Streptococcus faecalis, Streptococcus milleri and Viridans and
anaerobes such as Bacteroides species are increasingly common.
Unusual organisms are not uncommon in transplant recipients; Desir
et al. had isolated H. parainfluenzae in a kidney transplant patient with
polycystic kidney disease in a native liver cyst [10]. Additionally multi-
drug resistant bacteria are commonly seen in organ transplant
recipients [6-9]. In contrast to pyogenic abscesses, an amoebic
abscesses are common in countries with endemic amoebiasis and
suboptimal healthcare such as Mexico, India, East and South Africa,
and parts of Central and South America [3,11], hence, it should be
considered in residents of and travelers to these endemic areas, where
drinking water is contaminated by E. histolytica [3,4,11].
Amoebisis can disseminate through a hematogeneous route, thus
liver abscesses are by far the most common extra-intestinal
manifestation of invasive amebiasis. Amebic abscesses are usually
single and are normally located in the right hepatic lobe, though
multiples lesions can rarely occur, but they are infrequently reported
[11,12]. Moreover, amoebic abscess is 10 times more common in men
than in women while there is no gender predilection for a pyogenic
abscess.
Tuberculosis after solid organ transplantation remains unusual with
a variable incidence that can reach up to 15% in endemic areas of the
transplanted recipients [1,3]. Non-tuberculous mycobacterial
infections can be encountered too in immunosuppressed individuals,
commonly Mycobacterium avium complex followed with
Mycobacterium kansasii [13,14].
Diabetes mellitus, low serum albumin, and cytomegalovirus
seropositivity are all risk factors for bacteremia and hence liver abscess
formation; our patient was diabetic [9].
In our young patient, the most likely diagnosis was one of a
pyogenic abscess. Sterile culture probably is related to previous
antibiotic therapy. However, an amoebic abscess could not be ruled
out, considering his recent travel history to an endemic area of
amoebiasis (India), but the organism was not isolated, hence we
treated him for both.
Diagnosis
The classic triad of fever, right upper quadrant pain with tenderness
and jaundice on clinical examination is usually suggestive of the
diagnosis, however; they are rarely observed now, making the
diagnosis difficult especially in immunosuppressed patients. Clinical
signs, symptoms, and laboratory tests including liver test abnormalities
do not help to distinguish amoebic from pyogenic liver abscesses.
Serology for antibodies to E. histolytica is useful to determine current
or past infection [2,6,7,15,16].
As a diagnostic tool, ultrasonography is the primary imaging
modality for evaluating potential liver abscess, with accuracy and
sensitivity ranging from 80 -100%. Alternatively, CT scanning has
sensitivity similar to USS, and is usually performed to establish the
number of abscesses, which can be difficult on USS [2-6,11,15].
Magnetic Resonance Cholangiography is indicated in patients with
biliary symptoms, obstructive liver function tests or radiological
evidence of cholelithiasis or bile duct dilatation [8]. Diagnostic and
therapeutic transcutaneous aspiration is performed under ultrasound
or CT guidance, and the aspirate should be sent for culture and
cytology.
Medical therapy
Management in transplant recipients is not different to non-
transplanted patients [4,16]. Treatment involves antimicrobial therapy
with or without percutaneous or surgical drainage.
Antibiotic therapy
Diagnostic aspiration of abscess fluid, ideally under image guidance,
with subsequent culture can guide antibiotic choice. Failure to culture
pathogenic organisms can be attributed to previous antibiotic
treatment or inadequate anaerobic culture. The antimicrobial agent
should provide adequate coverage against aerobic gram-negative
bacilli, microaerophilic streptococci, and anaerobic organisms,
including Bacteroides fragilis. Usually, a combination of two or more
antibiotics is given.
Metronidazole and clindamycin have wider anaerobic coverage and
provide excellent penetration into the abscess cavity. A third-
generation cephalosporin or an aminoglycoside provides adequate
coverage against most gram-negative organisms; however, the use of
aminoglycosides in renal transplant recipients should be preserved for
severe resistant cases when benefits outweigh the risk.
Fluoroquinolones are used as an alternative for patients, who are
allergic to penicillin, extended-spectrum beta-lactamase (ESBL)
resistant bacteria needs to be treated accordingly. Antimicrobial
therapy should continue for 4 to 6 weeks [2,4,6,15,17]. If an amoebic
abscess is suspected; then treatment with Metronidazole for 10 days is
required [15,16].
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Occasionally, there is difficulty to distinguish between pyogenic and
amoebic abscesses; in such cases, anti-amoebic therapy is advised in
addition to broad-spectrum antibiotics [6].
Renal transplant recipients traveling to areas endemic for
amoebiasis should be counseled to avoid ingestion of potentially
contaminated food and water. Boiling water before use is essential to
destroy E. histolytica cysts [16].
Drainage of the abscess
By percutaneous aspiration guided by ultrasonography or computed
tomography, with or without placement of a drainage catheter, is
frequently required [2-4,6-9,16]. Small abscesses can be treated with
antibiotic therapy alone.
Residual liver abscess can persists in 5–28% of the cases,
independently of the treatment modality (medical or medical/
drainage). Of these cases; residual abscess have been noted to persist
up to 36 months and even longer in asymptomatic individuals. Follow
up with ultrasound scanning should be done in these cases [18,19].
Outcome and prognosis
If left untreated, pyogenic liver abscess will increase mortality rate to
reach 100%, nevertheless, with current therapy and early diagnosis, the
incidence can be reduced significantly to 15-20% [2,6].
Poor prognostic factors include elderly population, presence of
multiple abscesses, polymicrobial infection, hypoalbuminemia,
accompanied malignancy, multiple comorbidities and evidence of
sepsis [2,6,9].
Conclusions and Learning Points
Diagnosis of hepatic abscess in the transplant recipients is
challenging since presentation could be atypical.
Clinical signs, symptoms, laboratory tests and imaging cannot
distinguish amoebic from pyogenic liver abscesses.
Therapeutic management of hepatic abscess in transplant recipients
is similar to non-transplant patients.
If there is difficulty to distinguish between pyogenic and amoebic
abscesses, then anti-amoebic therapy should be considered, in addition
to antibiotics.
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